Related Experiment Videos
DNA probe technology: implications for service planning in Britain.
1Department of Public Health Medicine, United Medical School of Guy's Hospital, London, UK.
Clinical Genetics
|October 1, 1992
Summary
DNA testing aids prenatal decisions by identifying genetic carriers and fetal risks. Demand varies by condition severity, onset, and treatability, highlighting the need for coordinated genetic service planning.
Area of Science:
- Medical Genetics
- Clinical Diagnostics
- Public Health Genomics
Background:
- DNA testing is crucial for identifying carriers and assessing fetal risk in genetic conditions, informing prenatal decisions.
- Data from English and Welsh genetic centers (1986-1990) analyzed trends in DNA testing demand and impact.
- The study included 23,388 subjects across 8,738 families and 681 pregnancies.
Purpose of the Study:
- To describe trends in DNA testing demand and its impact on carrier risk assessment and pregnancy outcomes.
- To analyze the relationship between disease characteristics (severity, onset, treatability) and demand for DNA testing.
- To propose a framework for auditing and organizing DNA testing services for effective planning.
Main Methods:
- Retrospective analysis of data from three genetic centers in England and Wales.
- Categorization of families into five cohorts based on referral year.
- Assessment of DNA testing demand for specific genetic disorders including cystic fibrosis, Duchenne muscular dystrophy, and Huntington's disease.
Main Results:
- Demand for DNA testing was highest for cystic fibrosis and Duchenne muscular dystrophy, intermediate for Huntington's disease, and low for others.
- Initial high demand for certain genetic disorders has stabilized.
- Suggested demand patterns correlate with condition severity, onset age, and treatability.
Conclusions:
- Demand for DNA testing is influenced by the seriousness, treatability, and progression of genetic conditions.
- A coordinated structure is recommended to audit DNA testing services, aid policy formulation, and optimize supraregional service organization.
- Effective planning and monitoring of DNA services are essential for equitable access and resource allocation.